Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
Response to Stettler et al.
- Roger K. Schindhelm, MD, PHD, MEPI1,
- Michaela Diamant, MD, PHD2,
- Henk J. Bilo, MD, PHD, FRCP3 and
- Robbert J. Slingerland, PHD1
- 1Department of Clinical Chemistry, Isala Clinics, Zwolle, the Netherlands
- 2Department of Endocrinology/Diabetes Center, VU University Medical Center, Amsterdam, the Netherlands
- 3Department of Internal Medicine/Diabetes Center, Isala Clinics, Zwolle, the Netherlands
- Corresponding author: Roger K. Schindhelm, r.k.schindhelm{at}isala.net
In their very elegant study, Stettler et al. (1) assessed the association between 1,5-anhydroglucitol (1,5-AG) and postprandial glucose during different time periods, varying from 3 days to 12 weeks long, in patients with type 2 diabetes. They found the strongest association during a 2-week period. Although the authors excluded patients with overt renal insufficiency or proteinuria, it is as yet unknown whether additional adjustments for …
